Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies

Author： Evin Geneviève   Marijke Fleur Sernee   Masters Colin L.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.5, 2006-01, pp. : 351-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation

By  

Current Medicinal Chemistry, Vol. 18, Iss. 35, 2011-12 ,pp. : 5430-5447

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Alzheimer Therapeutic Drugs Targeting γ-Secretase

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 549-557

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase as a Therapeutic Target for the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3363-3382

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase as a Therapeutic Target in Alzheimer's Disease

By  

Current Drug Targets, Vol. 11, Iss. 4, 2010-04 ,pp. : 506-517

Bentham Science Publishers

Access to resources Recommend Favorite

Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer's disease: 2004 – 2008

By Garofalo Albert W  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 693-703

Informa Healthcare

Access to resources Recommend Favorite